Predicting medication noncompliance after hospital discharge among patients with schizophrenia

Psychiatric Services

Volumn 51, Issue 2, 2000, Pages 216-222

  Olfson, Mark ^b   Mechanic, David ^d   Hansell, Stephen ^d   Boyer, Carol A ^d   Walkup, James ^d   Weiden, Peter J ^a,c  

^a RUTGERS UNIVERSITY   (United States)

^b NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^c ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

NEUROLEPTIC AGENT;

ADULT; ARTICLE; COMORBIDITY; DISEASE EXACERBATION; FEMALE; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; SCHIZOPHRENIA; SUBSTANCE ABUSE; SUPPORT GROUP;

ADULT; ANTIPSYCHOTIC AGENTS; FEMALE; FOLLOW-UP STUDIES; HOSPITALS, GENERAL; HUMANS; MALE; MIDDLE AGED; NEW YORK CITY; PATIENT COMPLIANCE; PATIENT DISCHARGE; RECURRENCE; RISK FACTORS; SCHIZOPHRENIA; SEVERITY OF ILLNESS INDEX; SOCIAL SUPPORT; SUBSTANCE-RELATED DISORDERS; TREATMENT REFUSAL;

EID: 0033950999     PISSN: 10752730     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ps.51.2.216     Document Type: Article

References (36)

1. Fenton WS, Blyer CR, Heinssen RK: Determinants of medication compliance in schizophrenia: empirical and clinical findings. Schizophrenia Bulletin 23:637-651, 1997
2. Van Putten T, Crumpton E, Yale C: Drug refusal in schizophrenia and the wish to be crazy. Archives of General Psychiatry 33: 1443-1446, 1976
3. Pan PC, Tantam D: Clinical characteristics, health beliefs, and compliance with maintenance treatment: a comparison between regular and irregular attenders at a depot clinic. Acta Psychiatrica Scandinavica 79: 564-570, 1989
4. Kelly FR, Maimon JA, Scott HE: Utility of the health belief model in examining medication compliance among psychiatric outpatients. Social Science and Medicine 25:1205-1211, 1987
5. Pristach CA, Smith CM: Medication compliance and substance abuse among schizophrenic patients. Hospital and Community Psychiatry 41:1345-1348, 1990
6. Bartko G, Herezig I, Zador G: Clinical symptomalogy and drug compliance in schizophrenic patients. Acta Psychiatrica Scandinavica 77:74-76, 1988
7. Renton CA, Affleck JW, Carstair GM, et al: A follow-up of schizophrenic patients in Edinburgh. Acta Psychiatrica Scandinavica 39:548-600, 1963
8. Ayers T, Liberman RP, Wallace CJ: Subjective response to antipsychotic drugs: failure to replicate predictions of outcome. Journal of Clinical Psychopharmacology 4:89-93, 1984
9. Wilson JD, Enoch MD: Estimation of drug rejection by schizophrenic inpatients with analysis of clinical factors. British Journal of Psychiatry 113:209-211, 1967
10. Owen RR, Fischer EP, Booth EM, et al: Medication noncompliance and substance abuse among patients with schizophrenia. Psychiatric Services 47:853-858, 1996
11. Kashner TM, Rader LE, Rodell DE, et al: Family characteristics, substance abuse, and hospitalization patterns of patients with schizophrenia. Hospital and Community Psychiatry 42:195-197, 1991
12. Drake RE, Other FC, Wallace MA: Alcohol use and abuse in schizophrenia. Journal of Nervous and Mental Disease 177:408-414, 1989
13. Kovasznay B, Fleischer J, Tanenberg-Karant M, et al: Substance use disorder and the early course of illness in schizophrenia and affective psychosis. Schizophrenia Bulletin 23:195-201, 1997
14. Razali MS, Yahya H: Compliance with treatment in schizophrenia: a drug intervention program in a developing country. Acta Psychiatrica Scandinavica 91:331-335, 1993
15. Buchanan A: A two-year prospective study of treatment compliance inpatients with schizophrenia. Psychological Medicine 22:787-797, 1992
16. Weiden PJ, Dixon L, Frances A, et al: Neuroleptic noncompliance in schizophrenia, in Advances in Neuropsychiatry and Psychopharmacology: Schizophrenia Research, vol 1. Edited by Taminga CA, Schulz SC, New-York, Raven, 1991
17. Marder SR, Mebane A, Chien CP, et al: A comparison of patients who refuse and consent to neuroleptic treatment. American Journal of Psychiatry 140:470-472, 1983
18. McEvoy JP, Apperson LJ, Appelbaum PS, et al: Insight in schizophrenia: its relation to acute psychopathology. Journal of Nervous and Mental Disease 177:43-47, 1989
19. Nageotte C, Sullivan G, Duan N, et al: Medication compliance among the seriously mentally ill in a public mental health system. Social Psychiatry and Psychiatric Epidemiology 32:49-56, 1977
20. Kemp R, Kirov G, Everitt B, et al: Randomised controlled trial of compliance therapy. British Journal of Psychiatry 172:413-419, 1998
21. Cuffel BJ, Alford J, Fischer EP, et al: Awareness of illness in schizophrenia and outpatient treatment adherence. Journal of Nervous and Mental Disease 184:653-659, 1996
22. Frank AF, Gunderson JG: The role of the therapeutic alliance in the treatment of schizophrenia. Archives of General Psychiatry 47:228-236, 1990
23. Ruscher SM, de Wit R, Mazmanian D: Psychiatric patients' attitudes about medication and factors affecting noncompliance. Psychiatric Services 48:82-85, 1997
24. Hoge SK, Appelbaum PS, Lawlor T, et al: A prospective, multicenter study of patients' refusal of antipsychotic medication. Archives of General Psychiatry 47:949-956, 1990
25. Fleischhacker WW, Meise U, Gunther V, et al: Compliance with antipsychotic drug treatment: influence of side effects. Acta Psychiatrica Scandinavica 382(suppl): 11-15, 1994
26. Boyer CA, Olfson M, Kellermann SL, et al: Studying inpatient treatment practices in schizophrenia: an integrated methodology. Psychiatric Quarterly 66:293-320, 1995
27. Spitzer RL, Williams JBW, Gibbon M: Structured Clinical Interview for DSM-III-R: Patient Education (SCID-P, Version 1.0). Washington, DC. American Psychiatric Press, 1990
28. Overall JE, Gorham DP: Brief Psychiatric Rating Scale. Psychological Reports 10: 799-807, 1962
29. Endicott J, Spitzer RL, Fleiss JL, et al: The Global Assessment Scale. Archives of General Psychiatry 33:766-771, 1976
30. Sheehan DV, Lecrubier Y, Sheehan KH, et al: The Mini-International Neuropsychiatric Interview (MINI): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. Journal of Clinical Psychiatry, 59(suppl 20):22-33, 1998
31. Radloff LS: The CES-D Scale: a self-report depression scale for research in the general population. Applied Psychological Measurement 1:385-401, 1977
32. Manderscheid, RW, Sonnenschein MA (eds): Mental Health. United States, 1992. DHHS pub (SMA) 92-1942. Rockville, Md, Center for Mental Health Services, 1992
33. Weiden PJ, Mott T, Curico N: Recognition and management of neuroleptic noncompliance, in Contemporary Issues in the Treatment of Schizophrenia. Edited by Shriqui C, Nasrallah H. Washington, DC. American Psychiatric Press, 1995
34. Weiden P, Rapkin B, Mott T, et al: Rating of Medication Influences (ROMI) Scale in schizophrenia. Schizophrenia Bulletin 20:297-310, 1995
35. Kemp R, Hayward P, Applewhaite G, et al: Compliance therapy in psychotic patients: randomised controlled trial. British Medical Journal 312:345-349, 1996
36. Amador XF, Flaum M, Andreasen NC, et al: Awareness of illness in schizophrenia and schizoaffective and mood disorders. Archives of General Psychiatry 51:826-836, 1994